CRRL-269

N/A

Report date: 2025/01/26 18:08:06

Base Information

Drug NameCRRL-269
Drug Alias Nameparticulate guanylyl cyclase A peptide activator (Mayo Clinic)CRRL-269
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionNatriuretic peptide receptor 1 agonists
TargetsNatriuretic peptide receptor 1
Therapy Area/IndicationsRenal Insufficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMayo Clinic
China Registration ClassN/A

Develop Information

Active CompaniesMayo Clinic
Inactive CompaniesN/A
Active IndicationsRenal Insufficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A